Skip to content

Improving Colonoscopy Outcomes with a Ginger-Infused Carbohydrate Drink: Effects on Bowel Preparation and Patient Fatigue in a Randomized Controlled Trial

Improving Colonoscopy Outcomes with a Ginger-Infused Carbohydrate Drink: Effects on Bowel Preparation and Patient Fatigue in a Randomized Controlled Trial

Status
Recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
TCTR
Registry ID
TCTR20260309002
Enrollment
120
Registered
2026-03-09
Start date
2026-01-20
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon cancer Colonic neoplasm, Colonoscopy, ERAS, Well-being, Ginger, Bowel preparation

Interventions

carbohydrate beverage containing ginger extract (50 grams) dissolved in 500 mL of water. The beverage will be consumed approximately 1 to 2 hours after completing the first dose of polyethylene glycol
Experimental Dietary Supplement
carbohydrate beverage containing ginger extract

Sponsors

Faculty of Medicine, Prince of Songkla University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1 Patients aged 18 to 70 years undergoing colonoscopy at the Nantana Kriangkrai Chotiwatthanaphan Institute of Gastroenterology and Hepatology. 2 Scheduled for colonoscopy based on medical indications from the Internal Medicine Clinic, Internal Medicine Inpatient Building. 3 Willing to voluntarily provide informed consent to participate in the study.

Exclusion criteria

Exclusion criteria: 1. Patients with contraindications to oral intake, such as gastric outlet obstruction or intestinal obstruction. 2. Patients with poorly controlled underlying diseases (e.g., cardiovascular disease, chronic renal disease, etc.) with an ASA physical status classification of III or IV. 3. Patients with hemodynamic instability. 4. Individuals with a history of allergy to herbal extracts in the ginger family (e.g., ginger extract, Zingiberaceae). 5. Individuals with a history of allergy to polyethylene glycol. 6. Patients with acute lower gastrointestinal bleeding, inflammatory bowel disease, or a history of prior colorectal surgery. 7. Patients with cognitive impairment or psychiatric disorders that may interfere with assessment, altered consciousness, or inability to communicate. 8. Patients with severe dysphagia requiring nasogastric or gastrostomy tube feeding. 9. Pregnant women.

Design outcomes

Primary

MeasureTime frame
Well-being 1-2 hours before and after colonoscopy Visual analog scale

Secondary

MeasureTime frame
Bowel-preparation quality During colonoscopy Boston Bowel Preparation Scale

Countries

Thailand

Contacts

Public ContactPantawat Siviroch

Prince of Songkla University

bopantawat@gmail.com074451969

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026